Actinium Pharmaceuticals, Inc. (delaware) · AMEX:ATNM
BlackRock, Inc.'s stake in Actinium Pharmaceuticals, Inc. (delaware) fell to 1.50% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 16, 2025
BlackRock, Inc.'s stake in Actinium Pharmaceuticals, Inc. (delaware) fell to 1.50%, 462,969 shares, as a passive investor on Jun 30, 2025. Filed Jul 16, 2025 (Schedule 13G/A).
- Stake
- 1.50%
- Shares
- 462,969
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 1.50% | 462,969 |
Source
Related
- Actinium Pharmaceuticals, Inc. (delaware)
- BlackRock, Inc.
- Actinium Pharmaceuticals, Inc. (delaware) shareholders
- Form 4 · David Matthew T · Oct 16, 2026
- Form 4 · Nicholson, C. David · Sep 4, 2026
- Form 4 · Almenoff June Sherie · Sep 4, 2026
- Form 4 · Shetty Ajit · Sep 4, 2026
- Form 4 · Seth Sandesh · Sep 4, 2026